drugset / Trial / NCT00241137

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

NCT00241137

Phase 3 Completed 3790 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this was to evaluate valsartan 320mg compared to valsartan 160 mg in terms of blood pressure reduction in a patient population of mild to moderate hypertensives

Timeline

Start
2003-09
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Valsartan Small molecule 160 mg
Subject Valsartan Small molecule 320 mg

Indications